Clinical, morphological and immunological evaluation of six patients with dysferlin deficiency

Alessandro Prelle, M. Sciacco, L. Tancredi, G. Fagiolari, G. P. Comi, P. Ciscato, M. Serafini, F. Fortunato, C. Zecca, A. Gallanti, L. Chiveri, N. Bresolin, G. Scarlato, M. Moggio

Research output: Contribution to journalArticle

Abstract

Limb girdle muscular dystrophy (LGMD) type 2B and distal Miyoshi myopathy (MM) are caused by mutations in a recently discovered mammalian gene coding for a skeletal muscle protein called dysferlin. The protein is normally expressed at the skeletal muscle level and absent or reduced in affected patients. We selected a clinically heterogeneous population of Italian myopathic patients with clinical evidence of myopathy and/or hyperCKemia, EMG myopathic pattern, and no alterations of the dystrophin-sarcoglycan complex. Calpain, merosin, emerin and caveolin were also tested and found normal in all patients. Dysferlin immunohistochemical and Western blot analyses allowed us to identify six patients with dysferlin deficiency: one with distal myopathy, four with limb girdle myopathy and one with hyperCKemia. No apoptosis was found in any of the six muscle specimens, although expression of the pro-apoptotic Fas antigen was mildly increased in two cases. Inflammatory reactions were present in two of the six cases, but we found no evidence of immune-mediated processes.

Original languageEnglish
Pages (from-to)537-542
Number of pages6
JournalActa Neuropathologica
Volume105
Issue number6
Publication statusPublished - Jun 1 2003

Fingerprint

Muscular Diseases
Skeletal Muscle
Distal Myopathies
Sarcoglycans
Caveolins
CD95 Antigens
Dystrophin
Calpain
Muscle Proteins
Laminin
Extremities
Western Blotting
Apoptosis
Muscles
Mutation
Population
Genes
Proteins
Type 2B Limb-girdle muscular dystrophy
Miyoshi myopathy

Keywords

  • Apoptosis
  • Dysferlin
  • Lim-girdle dystrophy
  • Miyoshi myopathy
  • Muscle inflammation

ASJC Scopus subject areas

  • Clinical Neurology
  • Pathology and Forensic Medicine
  • Neuroscience(all)

Cite this

Clinical, morphological and immunological evaluation of six patients with dysferlin deficiency. / Prelle, Alessandro; Sciacco, M.; Tancredi, L.; Fagiolari, G.; Comi, G. P.; Ciscato, P.; Serafini, M.; Fortunato, F.; Zecca, C.; Gallanti, A.; Chiveri, L.; Bresolin, N.; Scarlato, G.; Moggio, M.

In: Acta Neuropathologica, Vol. 105, No. 6, 01.06.2003, p. 537-542.

Research output: Contribution to journalArticle

Prelle, A, Sciacco, M, Tancredi, L, Fagiolari, G, Comi, GP, Ciscato, P, Serafini, M, Fortunato, F, Zecca, C, Gallanti, A, Chiveri, L, Bresolin, N, Scarlato, G & Moggio, M 2003, 'Clinical, morphological and immunological evaluation of six patients with dysferlin deficiency', Acta Neuropathologica, vol. 105, no. 6, pp. 537-542.
Prelle, Alessandro ; Sciacco, M. ; Tancredi, L. ; Fagiolari, G. ; Comi, G. P. ; Ciscato, P. ; Serafini, M. ; Fortunato, F. ; Zecca, C. ; Gallanti, A. ; Chiveri, L. ; Bresolin, N. ; Scarlato, G. ; Moggio, M. / Clinical, morphological and immunological evaluation of six patients with dysferlin deficiency. In: Acta Neuropathologica. 2003 ; Vol. 105, No. 6. pp. 537-542.
@article{f729e430a3a64f229fe9ddd1bfaee10d,
title = "Clinical, morphological and immunological evaluation of six patients with dysferlin deficiency",
abstract = "Limb girdle muscular dystrophy (LGMD) type 2B and distal Miyoshi myopathy (MM) are caused by mutations in a recently discovered mammalian gene coding for a skeletal muscle protein called dysferlin. The protein is normally expressed at the skeletal muscle level and absent or reduced in affected patients. We selected a clinically heterogeneous population of Italian myopathic patients with clinical evidence of myopathy and/or hyperCKemia, EMG myopathic pattern, and no alterations of the dystrophin-sarcoglycan complex. Calpain, merosin, emerin and caveolin were also tested and found normal in all patients. Dysferlin immunohistochemical and Western blot analyses allowed us to identify six patients with dysferlin deficiency: one with distal myopathy, four with limb girdle myopathy and one with hyperCKemia. No apoptosis was found in any of the six muscle specimens, although expression of the pro-apoptotic Fas antigen was mildly increased in two cases. Inflammatory reactions were present in two of the six cases, but we found no evidence of immune-mediated processes.",
keywords = "Apoptosis, Dysferlin, Lim-girdle dystrophy, Miyoshi myopathy, Muscle inflammation",
author = "Alessandro Prelle and M. Sciacco and L. Tancredi and G. Fagiolari and Comi, {G. P.} and P. Ciscato and M. Serafini and F. Fortunato and C. Zecca and A. Gallanti and L. Chiveri and N. Bresolin and G. Scarlato and M. Moggio",
year = "2003",
month = "6",
day = "1",
language = "English",
volume = "105",
pages = "537--542",
journal = "Acta Neuropathologica",
issn = "0001-6322",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - Clinical, morphological and immunological evaluation of six patients with dysferlin deficiency

AU - Prelle, Alessandro

AU - Sciacco, M.

AU - Tancredi, L.

AU - Fagiolari, G.

AU - Comi, G. P.

AU - Ciscato, P.

AU - Serafini, M.

AU - Fortunato, F.

AU - Zecca, C.

AU - Gallanti, A.

AU - Chiveri, L.

AU - Bresolin, N.

AU - Scarlato, G.

AU - Moggio, M.

PY - 2003/6/1

Y1 - 2003/6/1

N2 - Limb girdle muscular dystrophy (LGMD) type 2B and distal Miyoshi myopathy (MM) are caused by mutations in a recently discovered mammalian gene coding for a skeletal muscle protein called dysferlin. The protein is normally expressed at the skeletal muscle level and absent or reduced in affected patients. We selected a clinically heterogeneous population of Italian myopathic patients with clinical evidence of myopathy and/or hyperCKemia, EMG myopathic pattern, and no alterations of the dystrophin-sarcoglycan complex. Calpain, merosin, emerin and caveolin were also tested and found normal in all patients. Dysferlin immunohistochemical and Western blot analyses allowed us to identify six patients with dysferlin deficiency: one with distal myopathy, four with limb girdle myopathy and one with hyperCKemia. No apoptosis was found in any of the six muscle specimens, although expression of the pro-apoptotic Fas antigen was mildly increased in two cases. Inflammatory reactions were present in two of the six cases, but we found no evidence of immune-mediated processes.

AB - Limb girdle muscular dystrophy (LGMD) type 2B and distal Miyoshi myopathy (MM) are caused by mutations in a recently discovered mammalian gene coding for a skeletal muscle protein called dysferlin. The protein is normally expressed at the skeletal muscle level and absent or reduced in affected patients. We selected a clinically heterogeneous population of Italian myopathic patients with clinical evidence of myopathy and/or hyperCKemia, EMG myopathic pattern, and no alterations of the dystrophin-sarcoglycan complex. Calpain, merosin, emerin and caveolin were also tested and found normal in all patients. Dysferlin immunohistochemical and Western blot analyses allowed us to identify six patients with dysferlin deficiency: one with distal myopathy, four with limb girdle myopathy and one with hyperCKemia. No apoptosis was found in any of the six muscle specimens, although expression of the pro-apoptotic Fas antigen was mildly increased in two cases. Inflammatory reactions were present in two of the six cases, but we found no evidence of immune-mediated processes.

KW - Apoptosis

KW - Dysferlin

KW - Lim-girdle dystrophy

KW - Miyoshi myopathy

KW - Muscle inflammation

UR - http://www.scopus.com/inward/record.url?scp=0038142687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038142687&partnerID=8YFLogxK

M3 - Article

C2 - 12734659

AN - SCOPUS:0038142687

VL - 105

SP - 537

EP - 542

JO - Acta Neuropathologica

JF - Acta Neuropathologica

SN - 0001-6322

IS - 6

ER -